Blood draw
Blood draw is a biological therapy with 399 clinical trials. Currently 98 active trials ongoing. Historical success rate of 90.1%.
Success Metrics
Based on 201 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
12
Mid Stage
20
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.0%
201 of 245 finished
18.0%
44 ended early
98
trials recruiting
399
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Lymphedema Surveillance Study
Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Exosomes in Rectal Cancer
Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation
Human Immune Response to Ixodes Scapularis Tick Bites
Clinical Trials (399)
Lymphedema Surveillance Study
Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Exosomes in Rectal Cancer
Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation
Human Immune Response to Ixodes Scapularis Tick Bites
Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging
Genetic Studies of Early-onset Dementia
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Circulating Tumor Cells (CTC) in Lung Cancer
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS
Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Immune Function and the Progression to T1D
Kidney Cancer DNA Registry
RANKL Inhibition and Mammographic Breast Density
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 399